- Fulcrum Therapeutics ( NASDAQ: FULC ) is down 6.0% after-hours after the firm has priced an underwritten public offering of 9,615,384 shares of its common stock at a public offering price of $13.00/share for expected gross proceeds to be $125M.
- All shares in the offering are to be sold by Fulcrum Therapeutics.
- Underwriters are granted a 30-day option to purchase up to an additional 1,442,307 shares of its common stock.
- Offering is expected to close on or about January 20, 2023.
For further details see:
Fulcrum Therapeutics shares slide after pricing $125M upsized stock offering